BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration

Phase 4 Unknown 20 enrolled Benha University

NaSingle-groupOpen-labelTreatment

Summary

Dystrophy-Related macular neovascularization degeneration occur is a vision threatening condition.The investigators evaluate the efficacy of BEOVU intravitreal treatment.

Timeline

Start: 2020-10-25
Primary completion: 2022-12-25
Completion: 2022-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brolucizumab	Other / unclassified	—	Intravitreal

BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration

Summary

Timeline

Drugs

Indications